trial
as of 2026-07-01Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography
NCTId NCT06278246
at a glance
Phase — · Active Not Recruiting
Enrollment 58 (estimated)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2026-03
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Active Not Recruiting
Enrollment
58 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2024-03-11
Primary completion
2026-03
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Investigators
1
Ariel Graff, MD, PhDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
58
Phase
NA
Primary Completion Date
2026-03
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator
person